Article PDF
References
Ikeda N, Hasegawa T, Hasegawa T, Saito I, Saruta T : Awareness of the Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2000) and compliance to its recommendations: surveys in 2000 and 2004. J Hum Hypertens 2006; 20: 263–266.
Nagai Y, Yao L, Kobori H, et al: Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. J Am Soc Nephrol 2005; 16: 703–711.
Hilgers KF, Veelken R : Type 2 diabetic nephropathy: never too early to treat? J Am Soc Nephrol 2005; 16: 574–575.
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981–2997.
Dahlof B, Devereux RB, Kjeldsen SE, et al, LIFE Study Group: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359: 995–1003.
Pfeffer MA, Swedberg K, Granger CB, et al, CHARM Investigators and Committees : Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 2003; 362: 759–766.
Julius S, Nesbitt SD, Egan BM, et al, Trial of Preventing Hypertension (TROPHY) Study Investigators : Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 2006; 354: 1685–1697.
Nakaya H, Sasamura H, Hayashi M, Saruta T : Temporary treatment of prepubescent rats with angiotensin inhibitors suppresses the development of hypertensive nephrosclerosis. J Am Soc Nephrol 2001; 12: 659–666.
Nakaya H, Sasamura H, Kitamura Y, et al: Effects of angiotensin inhibitors on renal injury and angiotensin receptor expression in early hypertensive nephrosclerosis. Hypertens Res 1999; 22: 303–312.
Ishiguro K, Sasanuma H, Sakamaki Y, Itoh H, Saruta T : Developmental activity of the renin-angiotensin system during the “critical period” modulates later L-NAME–induced hypertension and renal injury. Hypertens Res 2007; 30: 63–75.
Airoldi F, Palatresi S, Marana I, et al: Angioplasty of atherosclerotic and fibromuscular renal artery stenosis: time course and predicting factors of the effects on renal function. Am J Hypertens 2000; 13: 1210–1217.
Ramos F, Kotliar C, Alvarez D, et al: Renal function and outcome of PTRA and stenting for atherosclerotic renal artery stenosis. Kidney Int 2003; 63: 276–282.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kiyomoto, H., Hitomi, H. The Earlier, the Better. Hypertens Res 30, 1–2 (2007). https://doi.org/10.1291/hypres.30.1
Received:
Issue Date:
DOI: https://doi.org/10.1291/hypres.30.1